期刊文献+

肾移植术后爬行肌酐的综合治疗

Combined treatment of crawling creatinine following renal transplantation
下载PDF
导出
摘要 目的研究肾移植术后爬行肌酐的治疗对策及效果。方法对肾移植术后的20例爬行肌酐患者应用半量甲基泼尼松龙冲击治疗、更改免疫抑制药、应用活血化瘀药物、调整抗高血压药等治疗,观察2周后及3个月后的肌酐下降水平。结果 2周后18例患者血肌酐下降至平时水平,2例患者血肌酐水平停止爬行,维持在血肌酐爬行之前的水平;3个月后18例血肌酐下降的患者中14例血肌酐维持稳定,4例再次出现爬行肌酐;2例血肌酐水平停止爬行的患者血肌酐维持原有水平。结论肾移植术后爬行肌酐治疗关键在于及时发现、及时治疗,对于无穿刺病理活检条件的医院,综合治疗是一种较好的方法。 Objective To study the therapeutic strategy of crawling creatinine after kidney transplantation and its effect. Methods The 20 patients received renal transplantation,their crawling creatinine was treated with half the amount methylprednisolone pulse therapy,changing the immunosuppressant drugs,and using promoting blood circulation,adjusting antihypertensive therapy;after two weeks and three months the creatinine levels drop was observed. Results Among the 20 cases 18 after two weeks down to normal levels of serum creatinine,also two cases to stop crawling and maintain the level of serum creatinine before crawling;after three months in the 18 cases with serum creatinine decreased to normal serum level maintained stability ,4 cases occurred again crawling;the 2 cases of serum creatinine levels stopped crawling maintained their original level. Conclusion The key of treatment of crawling creatinine following renal transplantation is it timely detected and timely treated;for the hospitals without the conditions for performing puncture biopsy,comprehensive treatment is a better approach.
机构地区 解放军
出处 《实用医药杂志》 2015年第4期309-311,共3页 Practical Journal of Medicine & Pharmacy
关键词 治疗 肾移植 爬行肌酐 Therapy Kidney transplantation Crawling creatinine
  • 相关文献

参考文献16

  • 1Meier-KriescheHU,Schold JD,Kaplan B. Long term renal al- lograft survival have significant progress or is it time to rethink our analytic and therapeutic strategies? [J]. Am J Transplant, 2004,4(8) : 1289-1295.
  • 2SchererA, KrauseA, Walker JR, et al. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies[J]. Transplantation,2003, 75(8) : 1323-1330.
  • 3Nankivell BJ,Borrows RJ,Fung CL,et al. The natural history of chrouic allograft nephropathy[J]. N Engt Med,2003,349 (24) : 2326-2333.
  • 4Paul LC ,de Fijter JH. Cyclosporine induced renal dysfunction [J]. Transplant Proc,2004,36($2):$224-$228.
  • 5Wang T,Donahoe PK,Zervos AS. Specific interaction of typeI receptors of the TGF-beta family with the immunophilin FKBP-12[J]. Science,1994,265(5172):674-676.
  • 6Kurian SM,Heilman R,Mondala TS,et al. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood[J]. PLo Sone,2009,4(7):e6212.
  • 7Qin XP,Ye F,Liao DF,et al.Involvement of calciton in gener- elated peptide in depressor effects of losartan and perindopril in rats [ J 3. Eur J Pharmacol, 2003,464 ( 1 ) : 63-67.
  • 8Uzu T, Nishimura M ,Fujii T,et al.Benidipine attenuates glom- errulerhy pertension and reduces albuminuria in patients with metabolic syndrome[J]. Hypertens Res,2007,30(2) : 161-165.
  • 9Akizuki 0 ,lnayoshi A,Kitayama T,et al. Blockade of T-type voltage-dependent Ca2 channels by benidipine A dihydropy- ridine calcium channel blocker,inhibits aldosterone production in human adrenocortical cellline NCI-H295R[J]. Eur J Phar- maeol,2008,584(4) :424-434.
  • 10Saito F,Fujita H,Takahashi A,et al.Renoprotective effect and cost-effectiveness of using benidipine,a calcium channel blo- cker,to lower the dose of angiotensin receptor blocker in hy- pertensive patients with albuminuria[J]. Hylxntens Res,2007, 30(1 ) :39-47.

共引文献349

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部